Stay updated on Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Sign up to get notified when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.

Latest updates to the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page
- Check4 days agoChange DetectedRemoved Prostate cancer as a related topic and the MedlinePlus Genetics topic, and added Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check11 days agoChange DetectedAdded related topics 'Prostate cancer' and 'MedlinePlus Genetics' to the Study Details page as metadata to aid navigation. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check18 days agoChange DetectedProstate cancer condition tag and MedlinePlus Genetics topic were removed from the study page.SummaryDifference0.2%

- Check25 days agoChange DetectedAdded Prostate cancer and related topics (MedlinePlus Genetics), and Locations (Oregon). Removed HHS Vulnerability Disclosure and Oregon Locations; Revision updated to v3.3.3.SummaryDifference0.4%

- Check53 days agoChange DetectedPublications are now described as automatically filled from PubMed with a revision tag of v3.3.2; the previous description referred to PubMed-listed publications with revision v3.2.0.SummaryDifference0.1%

- Check61 days agoChange DetectedThe administrative notice about government funding and NIH operating status has been removed from the page.SummaryDifference0.4%

Stay in the know with updates to Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Neo-Pembrolizumab + Androgen Blockade in Prostatectomy Clinical Trial page.